Oxford Outcomes, Inc., An ICON plc Company, 7315 Wisconsin Ave., Suite 250W, Bethesda, MD, 20814, USA,
Patient. 2013;6(3):225-31. doi: 10.1007/s40271-013-0021-4.
The Urticaria Patient Daily Diary (UPDD), originally developed on paper, is a measure of key symptoms of chronic idiopathic urticaria (CIU). The development of the electronic version (eUPDD) involved moderate modifications to the appearance of the paper version.
This study assessed the measurement equivalence of the electronic and paper versions of the UPDD in a sample of patients with CIU.
This was a cross-over study of patients with moderate-severe CIU refractory to H1 antihistamines. Patients were randomized to either the eUPDD followed by the paper UPDD or vice versa. The UPDD includes morning and evening questions; both sets were administered together in this study. An hour-long filler task was given between paper and electronic administrations. Patients with stable symptoms between the two assessments were included in the analyses. Cohen's kappa coefficients and intraclass correlation coefficients (ICC) were computed as applicable to assess equivalence.
A total of 91 patients participated (mean age 43 years, 79.1 % female). Symptoms were stable between assessments for 67-74 (74-81 %) patients (varied by symptom). Kappa coefficients ranged from 0.82 to 1.00 for the individual UPDD items. For the Urticaria Activity Score (the sum of the 'itch severity' and 'number of hives' item scores) the ICC was 0.90 for the morning (Wilcoxon p = 0.331) and 0.95 for the evening (Wilcoxon p = 0.836).
All test-retest statistics in this study were well above the accepted threshold, indicating excellent agreement between the two administration methods. Findings support the measurement equivalence of the electronic and paper versions of the UPDD to measure CIU symptoms.
最初以纸质形式开发的荨麻疹患者日常日记(UPDD)是慢性特发性荨麻疹(CIU)关键症状的一种测量手段。电子版本(eUPDD)的开发涉及对纸质版本外观的适度修改。
本研究旨在评估 CIU 患者样本中 UPDD 的电子和纸质版本的测量等效性。
这是一项对 H1 抗组胺治疗难治性中度至重度 CIU 患者的交叉研究。患者随机分为 eUPDD 组和纸质 UPDD 组,或反之。UPDD 包括早晨和晚上的问题;在这项研究中同时进行了这两套问题。在纸质和电子管理之间进行了长达一个小时的填充任务。仅纳入两次评估时症状稳定的患者进行分析。
共有 91 名患者参与(平均年龄 43 岁,79.1%为女性)。67-74 项(因症状而异)患者的症状在两次评估之间稳定。个体 UPDD 项目的kappa 系数范围为 0.82 至 1.00。对于荨麻疹活动评分(“瘙痒严重程度”和“风团数量”项目评分之和),早晨的 ICC 为 0.90(Wilcoxon p = 0.331),晚上的 ICC 为 0.95(Wilcoxon p = 0.836)。
本研究中的所有测试 - 重测统计数据均远高于可接受的阈值,表明两种管理方法之间具有极好的一致性。研究结果支持 UPDD 的电子和纸质版本在测量 CIU 症状方面具有测量等效性。